C1 inhibitor, C3 activator, IgG, IgA, and IgM titers in Nigerian sickle cell disease patients with Plasmodium falciparum

Iranian Journal of Immunology

Volumn 4, Issue 1, 2007, Pages 44-49

  Arinola, Ganiyu ^a   Ezeh, Chris ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Malaria; Nigeria; Sickle cell

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY TITER; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; GENOTYPE; HUMAN; IMMUNODIFFUSION; IMMUNOGLOBULIN BLOOD LEVEL; MORBIDITY; MORTALITY; NIGERIA; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; SICKLE CELL ANEMIA; STATISTICAL SIGNIFICANCE;

EID: 34249092684     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Akinyanju O. Issues in the Management and Control of Sickle Cell Disorder. Archives of Ibadan Medicine. 2001; 2: 237-41.
2. Cornille-Brogger R, Fleming AF, Kagan I, Matsushima T, Molineaux L. Abnormal haemoglobins in the Sudan savanna of Nigeria. II. Immunological response to malaria in normals and subjects with sickle cell trait. Ann Trop Med Parasitol. 1979 ;73:173-83.
3. Marsh K. Malaria - a neglected disease? Parasitology. 1992;104 :53-69.
4. Adeloye A, Odeku EL. The nervous system in sickle cell disease. Afr J Med Sci. 1970 ;1: 33-48.
5. Maharajan R, Fleming AF, Egler LJ. Pattern of infections among patients with sickle-cell anaemia requiring hospital admissions. Nig J Paediatr 1983;10: 13-7.
6. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature. 2002 ;415:673-9.
7. De Cock KM, Hodgen AN, Jupp RA, Slavin B, Siongok TK, Rees PH et al. Immunoglobin M and malarial antibody levels in hyper-reactive malarial splenomegaly.J Trop Med Hyg. 1986 ;89:119-21.
8. Biswas S, Saxena QB, Roy A. The natural occurrence of circulating antibodies in populations of endemic malarious areas. Indian J Malariol. 1990 ;27:139-48.
9. Neva FA, Howard WA, Glew RH, Krotoski WA, Gam AA, Collins WE et al. Relationship of serum complement levels to events of the malarial paroxysm.J Clin Invest. 1974; 54:451-60.
10. Jhaveri KN, Ghosh K, Mohanty D, Parmar BD, Surati RR, Camoens HM et al. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria.Natl Med J India. 1997 ;10:5-7.
11. Dieye TN, Ndiaye O, Ndiaye AB, Thiam D, Fall-Seck K, Diop S et al. Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal Dakar. Dakar Med. 1999; 44:175-9.
12. Adekile AD, Haider MZ ,Serebour F, Al-Zaabi K, Tuli M. Serum Immunoglobulins and IgG Subclasses in SS Patients with Saudi Arabia/India Haplotype. Med Principle Pract .1999; 8 :183 - 8.
13. Odegbemi JO, Williams AI. Immunoglobulin levels in malaria infected Nigerians with and without abnormal Haemoglobin. Afr J Med Med Sci. 1995 ;24:21-5.
14. Rowe A, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun. 1995 ;63:2323-6.
15. Bull PC, Marsh K. The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria.Trend Microbiol. 2002.10: 55-8.
16. Mohapatra BN, Dash BP, Kar BC. Serum immunoglobulins in sickle cell disease. J Assoc Physicians India. 1993; 41:418-9.
17. Marwah GS, Arora S, Prabhakar H. Haemagglutination antibody titres & immunoglobulin levels in cases of Plasmodium infection.Indian J Med Res. 1989; 89:326-9.
18. Fribourg-Blanc A, Druilhe P, Brasseur P, Rhodes-Feuillette A, Ballet JJ, Tharavanij S. Immunological evaluation of cellmediated and humoral immunity in Thai patients with cerebral and non cerebral Plasmodium falciparum malaria: II. Evolution of serum levels of immunoglobulins, anti malarial antibodies, complement fractions and alpha interferon. Southeast Asian J Trop Med Public Health. 1985; 16: 307-13.